Clinical Trials Logo

Clinical Trial Summary

This is a single-center, randomized, controlled, open-label, cross-over study with healthy adult smokers. The study will investigate the nicotine pharmacokinetic (PK) profiles of two e-liquid variants used with the P4M3 Gen 2.0 e-cigarette, compared to smoking combustible cigarettes. In addition, pharmacodynamic (PD) effects (subjective effects and related behavioral assessments), will be evaluated to provide further insights on product evaluation, craving, liking, puffing topography. The study will be conducted with three periods and six sequences in a cross-over design. This study is exploratory and there is no pre-specified hypothesis to be tested.


Clinical Trial Description

The purpose of the study is to evaluate the nicotine pharmacokinetics (PK) profiles of two e-liquid variants used with the P4M3 Gen 2.0 e-cigarette versus cigarettes following a six minutes ad libitum use period. In addition, pharmacodynamic effects (PD), including subjective effects and related behavioral assessments, as well as human puffing topography (HPT) will be evaluated, to provide further insights on P4M3 Gen 2.0 product acceptance and product use. Safety will be assessed throughout the study. The aim is to evaluate if P4M3 Gen 2.0 can provide an acceptable alternative to smoking cigarettes in terms of both, nicotine delivery and sensorial satisfaction for current adult smokers who would otherwise continue smoking cigarettes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05383508
Study type Interventional
Source Philip Morris Products S.A.
Contact
Status Completed
Phase N/A
Start date April 28, 2022
Completion date August 25, 2022

See also
  Status Clinical Trial Phase
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Recruiting NCT05454267 - Early Detection of Vaping-related Vascular Diseases
Enrolling by invitation NCT04678245 - Network Intervention to Prevent Vaping N/A
Recruiting NCT06297005 - The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Completed NCT04522362 - Modeling Stress-precipitated Vaping Behavior N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Recruiting NCT06291597 - Vaping Adverse Lung and Heart Events Cohort
Active, not recruiting NCT04919590 - Text Message Quit Vaping Intervention for Adolescents N/A
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT04707911 - Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents N/A
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06335329 - Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping N/A
Completed NCT06433466 - Influencer Marketing: a Survey-based Experiment N/A
Active, not recruiting NCT05488743 - Smoking Prevention Program in Poland
Terminated NCT05240027 - To Vape or Not to Vape N/A
Recruiting NCT04661683 - Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol N/A
Completed NCT04450537 - PACE Vape Messaging Study N/A
Active, not recruiting NCT05367492 - Varenicline for Nicotine Vaping Cessation in Adolescents Phase 4
Completed NCT04879225 - Menthol and Mint Experimental Tobacco Marketplace (ETM) Study N/A